Matinas BioPharma MTNB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | 9.18 | 117.19 | -3.15 | -1,554 | -1 | |
| 2026Q1 | 7.5 | 100.78 | -4.5 | -1,936 | -2 | |
| 2025Q4 | 8.79 | 83.68 | -3.9 | -1,600 | -2 | |
| 2025Q3 | 28.35 | 102.94 | -5.7 | -1,577 | -2 | |
| 2025Q2 | 13.35 | 35.02 | -15.45 | -1,837 | -5 | |
| 2025Q1 | 7.8 | 117.51 | -4.95 | -1,946 | -2 | |
| 2024Q4 | 7.65 | 99.48 | -25.2 | -8,469 | -8 | |
| 2024Q3 | 53.1 | 102.5 | -12.45 | -4,382 | -4 | |
| 2024Q2 | 118.73 | 102.12 | -16.95 | -5,840 | -6 | |
| 2024Q1 | 203.25 | 101.34 | -20.1 | -5,902 | -6 | |
| 2023Q4 | 162.15 | 110.78 | -18.3 | -5,887 | -5 | |
| 2023Q3 | 97.5 | 101.3 | -23.4 | -6,134 | -6 | |
| 2023Q2 | 270 | 101.63 | -15 | -6,159 | -6 | |
| 2023Q1 | 352.5 | 101.32 | -22.5 | -5,586 | -6 | |
| 2022Q4 | 375 | 150.8 | -15 | -5,480 | -4 | |
| 2022Q3 | 477 | 100.02 | -15 | -5,462 | -5 | |
| 2022Q2 | 592.5 | 100.05 | -22.5 | -5,926 | -6 | |
| 2022Q1 | 603.3 | 129.17 | -22.5 | -7,722 | -6 | |
| 2021Q4 | 757.5 | 100.22 | -22.5 | -6,714 | -7 | |
| 2021Q3 | 975 | 100.6 | -22.5 | -6,878 | -7 |